Live Breaking News & Updates on Cell Type Specific Targeting
Stay updated with breaking news from Cell type specific targeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2nd March 2021 11:23 am 2nd March 2021 11:23 am An international project aims to create new photonic tools that can access the deep brain and provide further understanding of neurological diseases. Image by Colin Behrens from Pixabay Strathclyde University is the UK participant in DEEPER (Deep Brain Photonic Tools for Cell-Type Specific Targeting of Neural Diseases), which is investigating the deep-brain alterations underlying the origin of neurological and psychiatric diseases such as dementia, depression, addiction, schizophrenia and chronic pain. The four-year study involves 12 partners in eight countries, coordinated by Italian Institute of Technology (IIT), and has received funding of approximately €5.7m from the European Union via the Horizon 2020 programme. ....
International Consortium to Develop Photonic Tools for Deep Brain Imaging | Business | Jan 2021 photonics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from photonics.com Daily Mail and Mail on Sunday newspapers.
E-Mail Genova/Lecce (Italy), 28th January 2021 - Understanding and treating brain disorders, such as Alzheimer s disease, addiction, chronic pain, depression and schizophrenia, entails the comprehension of the alterations that may occur in the deep regions of the gray matter. Thanks to the European-funded project DEEPER, an international research consortium, coordinated by IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), will develop new photonic technologies to access those regions and reveal the molecular and cellular dysfunctions underlying the origin of the disorder. The new technological tools are developed with the goal to directly treat the diseases in a minimally invasive and highly effective way. DEEPER will transfer the technological results from laboratory to market, with the ambition to have an impact to strengthen Europe s industrial position in the biophotonics market. ....